Varian Medical Systems (NASDAQ: BLFS) and BioLife Solutions (NASDAQ:BLFS) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership.
Institutional and Insider Ownership
92.4% of Varian Medical Systems shares are held by institutional investors. Comparatively, 27.8% of BioLife Solutions shares are held by institutional investors. 0.8% of Varian Medical Systems shares are held by company insiders. Comparatively, 38.5% of BioLife Solutions shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Volatility & Risk
Varian Medical Systems has a beta of 0.79, indicating that its stock price is 21% less volatile than the S&P 500. Comparatively, BioLife Solutions has a beta of 1.46, indicating that its stock price is 46% more volatile than the S&P 500.
Valuation & Earnings
This table compares Varian Medical Systems and BioLife Solutions’ revenue, earnings per share (EPS) and valuation.
||Earnings Per Share
|Varian Medical Systems
Varian Medical Systems has higher revenue and earnings than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than Varian Medical Systems, indicating that it is currently the more affordable of the two stocks.
This table compares Varian Medical Systems and BioLife Solutions’ net margins, return on equity and return on assets.
||Return on Equity
||Return on Assets
|Varian Medical Systems
This is a summary of current ratings and target prices for Varian Medical Systems and BioLife Solutions, as provided by MarketBeat.com.
||Strong Buy Ratings
|Varian Medical Systems
Varian Medical Systems currently has a consensus target price of $113.33, suggesting a potential upside of 2.98%. BioLife Solutions has a consensus target price of $22.33, suggesting a potential upside of 23.32%. Given BioLife Solutions’ stronger consensus rating and higher possible upside, analysts plainly believe BioLife Solutions is more favorable than Varian Medical Systems.
Varian Medical Systems beats BioLife Solutions on 8 of the 14 factors compared between the two stocks.
About Varian Medical Systems
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Varian Particle Therapy. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy. Its products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, and accessories; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, oncology practices, radiotherapy centers, and cancer care clinics. The Varian Particle Therapy segment develops, designs, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. Varian Medical Systems, Inc. has a strategic partnership with Siemens AG to co-develop new imaging and treatment solutions. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.
About BioLife Solutions
BioLife Solutions, Inc. develops, manufactures, and markets patented tissue hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs in the United States. Its products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, and delayed-onset cell damage and death. The company offers HypoThermosol FRS, a hypothermic storage and shipping media product to mitigate temperature-induced molecular cell stress responses that occur during chilling and re-warming of biologics, intermediate products, and final cell products intended for research and clinical applications; and CryoStor cryopreservation freeze media products to mitigate temperature-induced molecular cell stress responses during freezing and thawing. It also provides BloodStor freeze media products, such as BloodStor 55-5 and BloodStor 100 for cryopreservation of stem and other cells isolated from umbilical cord and peripheral blood, and bone marrow; and cell thawing media, which offers Dextran and saline for washing cryopreserved cells and tissues to dilute or remove cryoprotectants. In addition, the company provides custom product formulation and packaging services; and contract aseptic manufacturing formulation, filling, and finishing services for liquid media products. It markets its products to the regenerative medicine, bio-banking, and drug discovery markets, including hospital-based stem cell transplant centers, pharmaceutical companies, cord blood and adult stem cell banks, and hair transplant centers, as well as suppliers of cells to the drug discovery, toxicology testing, and diagnostic markets. The company markets and sells its products directly using its sales force, as well as through biolifesolutions.com; and through various regional distributors. BioLife Solutions, Inc. was founded in 1987 and is headquartered in Bothell, Washington.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.